Jul 17, 2026 04:00PM
Jul 7, 2026 07:30AM
Jun 17, 2026 04:00PM
Jun 8, 2026 07:30AM
Jun 1, 2026 07:32AM
Jun 1, 2026 07:30AM
May 27, 2026 04:00PM Cytokinetics to Participate in June Investor Conferences
May 20, 2026 04:00PM
May 18, 2026 04:00PM
May 14, 2026 07:30AM
May 12, 2026 04:00PM
May 11, 2026 10:08AM
May 11, 2026 10:06AM
May 5, 2026 04:05PM Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026 07:30AM
May 5, 2026 07:30AM
May 4, 2026 04:00PM
May 4, 2026 04:00PM
Apr 28, 2026 07:31AM
Apr 28, 2026 07:30AM
Apr 21, 2026 04:00PM Cytokinetics to Announce First Quarter Results on May 5, 2026
Apr 20, 2026 04:00PM
Apr 6, 2026 04:00PM
Mar 16, 2026 08:00AM
Mar 2, 2026 04:00PM
Feb 24, 2026 04:00PM
Feb 17, 2026 07:38AM
Feb 17, 2026 07:30AM Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Feb 12, 2026 04:00PM
Feb 9, 2026 07:30AM
Jan 27, 2026 08:00AM
Jan 27, 2026 07:32AM
Jan 27, 2026 07:30AM
Jan 20, 2026 04:00PM
Jan 8, 2026 08:59AM Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Graba
Jan 7, 2026 08:47AM
Jan 5, 2026 04:00PM
Jan 2, 2026 09:05AM
Dec 30, 2025 09:57AM
Dec 29, 2025 08:49AM
Dec 22, 2025 09:13AM
Dec 22, 2025 07:25AM Cytokinetics (CYTK) PT Raised to $84 at Needham
Dec 22, 2025 07:09AM
Dec 22, 2025 06:44AM
Dec 22, 2025 06:40AM
Dec 21, 2025 08:00PM
Dec 19, 2025 04:00PM
Dec 19, 2025 04:00PM
Dec 19, 2025 04:00PM Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
Dec 19, 2025 08:27AM

326,260 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All